{"filing":{"accession_number":"0001193125-26-427256","cik":"0001715925","ticker":"HYFT","company_name":"MindWalk Holdings Corp.","form":"6-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"press_release_oct_21_202.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1715925/000119312526427256/press_release_oct_21_202.htm"},"events":[{"id":36622,"run_id":33767,"accession_number":"0001193125-26-427256","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This press release announces a technical benchmark demonstrating that MindWalk's LensAI™ immunogenicity screening platform achieved significant performance and cost improvements (37% faster, 43% lower cost per sequence) on AMD EPYC processors compared to Intel alternatives. The disclosure highlights a deepening engineering relationship with AMD and describes how architectural improvements to the underlying ReefIQ™ platform enable cost reduction at enterprise scale. While primarily a product/technology announcement rather than a discrete corporate event, the material cost reduction (43%) on a \"heavy workload\" and its direct impact on enterprise platform margins and the company's path to \"contracted, recurring revenue\" make this operationally material to investors assessing the registrant's ability to scale its business model profitably.","company_name":"MindWalk Holdings Corp.","ticker":"HYFT","filing_date":"2026-10-21","form":"6-K","submitted_at":null,"items":[{"id":41095,"accession_number":"0001193125-26-427256","item_number":"EX-99.1","item_title":"hyft-ex99_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release announces a technical benchmark demonstrating that MindWalk's LensAI™ immunogenicity screening platform achieved significant performance and cost improvements (37% faster, 43% lower cost per sequence) on AMD EPYC processors compared to Intel alternatives. The disclosure highlights a deepening engineering relationship with AMD and describes how architectural improvements to the underlying ReefIQ™ platform enable cost reduction at enterprise scale. While primarily a product/technology announcement rather than a discrete corporate event, the material cost reduction (43%) on a \"heavy workload\" and its direct impact on enterprise platform margins and the company's path to \"contracted, recurring revenue\" make this operationally material to investors assessing the registrant's ability to scale its business model profitably.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T12:30:38.739162+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41095,"accession_number":"0001193125-26-427256","item_number":"EX-99.1","item_title":"hyft-ex99_1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This press release announces a technical benchmark demonstrating that MindWalk's LensAI™ immunogenicity screening platform achieved significant performance and cost improvements (37% faster, 43% lower cost per sequence) on AMD EPYC processors compared to Intel alternatives. The disclosure highlights a deepening engineering relationship with AMD and describes how architectural improvements to the underlying ReefIQ™ platform enable cost reduction at enterprise scale. While primarily a product/technology announcement rather than a discrete corporate event, the material cost reduction (43%) on a \"heavy workload\" and its direct impact on enterprise platform margins and the company's path to \"contracted, recurring revenue\" make this operationally material to investors assessing the registrant's ability to scale its business model profitably.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T12:30:38.739162+00:00","company_name":"MindWalk Holdings Corp.","ticker":"HYFT","filing_date":"2026-10-21"}]}